COMMUNIQUÉS West-GlobeNewswire

Strongbridge Biopharma plc Strengthens Senior Leadership Team with Key Promotion and Appointment
04/06/2019
Scott Wilhoit Promoted to Chief Commercial Officer Marcy Nanus Appointed Vice President of Corporate Affairs DUBLIN, Ireland and TREVOSE, Pa., June 04, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP [...]
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 40th Annual Global Healthcare Conference
04/06/2019
CAMBRIDGE, Mass., June 04, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’
04/06/2019
In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial dysfunction in patients with [...]
YSS Corp.™ (Formerly Solo Growth Corp.) Announces Share Consolidation Details and New Ticker “YSS”
04/06/2019
CALGARY, Alberta, June 04, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (formerly Solo Growth Corp., the “Company” or “YSS”) (TSXV: SOLO) (WKN:A2PBMC) a cannabis retailer operating as YSS TM with the vision to become a premier [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2019
SANTA BARBARA, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ( “Sientra” or the “Company”), a medical aesthetics company, today announced that on May 30, 2019, the Compensation Committee of the [...]
Lexicon Pharmaceuticals to Present New Clinical Data at 79th American Diabetes Association Scientific Sessions
04/06/2019
THE WOODLANDS, Texas, June 04, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced new analyses of clinical data for sotagliflozin will be presented at the upcoming 79 th American [...]
First Patient Enrolled and Dosed in Novan’s SB206 Phase 3 Molluscum Program
04/06/2019
Phase 3 pivotal program commences and underway Investigative sites now activated and enrollment activities actioned Anticipated patient demand managed with a highly disciplined approach to trial execution Top line [...]
Amarin to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
04/06/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, June 04, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Athersys to Present at Jefferies 2019 Healthcare Conference
04/06/2019
Conference being held June 4-7, 2019 in New York City CLEVELAND, June 04, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the Jefferies [...]
Transactions in relation to share buyback program
04/06/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Coloplast announcement no. 05/2019 - Comment on market rumours
04/06/2019
Announcement no. 5/2019 Comment on market rumours Coloplast confirms that the company is conducting an unconditional strategic review of its Interventional Urology division. Further information will be communicated to [...]
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
04/06/2019
Amsterdam, The Netherlands – 04 June 2019 Jouvene’s new innovative offer will empower people with disease prevention, detection, diagnosis, treatment and management. With more than 10,000 diseases and medical conditions [...]
Cocoon Medical Appoints Miguel Pardos as Chief Executive Officer
04/06/2019
Barcelona, Spain, May. 27, 2019 – Cocoon Medical (“Cocoon”), a leading developer and provider of energy-based aesthetic systems for practitioners worldwide, today announced the appointment of Miguel Pardos as its Chief [...]
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whle Genome Sequencing for Consumer distribution.
04/06/2019
Amsterdam, The Netherlands – 04 June 2019 Jouvene’s new innovative offer will empower people with disease prevention, detection, diagnosis, treatment and management. With more than 10,000 diseases and medical conditions [...]
Information on total number of voting rights and shares composing the share capital as at May 31st, 2019
04/06/2019
Paris, June 3 rd , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2019
04/06/2019
Paris, le 3 juin 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de façon [...]
New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019
04/06/2019
- Several scientific conference contributions outline benefits of U.S. FDA-cleared Unyvero LRT Application Cartridge in both endotracheal aspirate and bronchoalveolar lavage samples - Study shows that Unyvero LRT has [...]
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL
04/06/2019
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL Biopharmaceutical veteran Edwina Baskin-Bey, M.D., joins Nanobiotix as its new Chief Medical Officer ( [...]
Nanobiotix nomme un nouveau directeur médical à la suite de son autorisation de mise sur le marché européen
04/06/2019
NANOBIOTIX NOMME UN NOUVEAU DIRECTEUR M É DICAL À LA SUITE DE SON AUTORISATION DE MISE SUR LE MARCH É EUROP É EN Experte de l’industrie Biopharmaceutique, le Dr. Edwina Baskin-Bey rejoint Nanobiotix en tant que nouveau [...]

Pages